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Implementation
•  The initial plan was to round on 
patients to visualize PIV’s (assess 
the site, condition of dressing, line 
reconciliation, etc.).
•  Due to COVID and restricted visiting, 
chart audits and communication 
with nurses became the major 
source of PIV monitoring. Chart 
audits were performed to view 
documented number of hours PIV 
dwell > 96, potential complications 
and adherence to policy. 
•  RN’s documented assessment of 
PIV site every 4 hours. There was 
consistent and frequent 
communication (via telephone) with RNs to ensure PIV’s functioning with no 
signs of infection, infiltration, inflammation, or phlebitis. 
Outcomes
nurses’ time saved
•  25 PIV’s with >96 dwell time.
•  Total PIV hours with > 96-hour dwell was 972 hours. 
•  Nurse’s time saved was 39 hours. This time was allotted to other patient 
care activities. 
cost savings
•  Cost saving was approximately $600 over the three-month period.
Patient Satisfaction
•  Patient satisfaction scores increased during the pilot. Overall score of 84% 
during the first quarter (prior to the pilot) and 87% during the second 
quarter (during the pilot). 
impact on complications
•  There were no complications (infection, inflammation, infiltration, phlebitis) 
related to PIV dwell more than 96 hours (PIV in place up to 240 hours 
during this pilot).
•  An unexpected outcome: some PIV <96-hour dwell were removed and 
not replaced. 
Next Steps
•  Share results with director, staff and other stakeholders. 
•  These discussions will be held 1:1, during huddles and team meetings. 
•  In addition to sharing results at this location, the project and results will be 
presented to Network Leadership. Network by-in, support of the evidence, 
will lead to consideration of policy change.
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Background
•  Current policy requires peripheral intravenous (PIV) catheters to be replaced 
every 96 hours. 
•  Patients often require intravenous (IV) therapy (antibiotics, fluids etc.) beyond 
the initial 96 hours.
•  Raising questions about costs, workflow and patient satisfaction
PICO Question
In adult medical surgical patients, does replacing peripheral intravenous 
catheters every 96 hours (current practice) compared to replacing peripheral 
intravenous catheters when clinically indicated impact peripheral intravenous 
catheter complications?
Evidence
 Xu, L., Hu Y., Huang, X, 
Fu, J., Zang, J., (2017) 
Clinically indicated Peripheral Intervenors catheter 
replacement is feasible and may reduce nursing staff 
workload and patient t discomfort.
Barnhart, E., Always, A., 
Halm, M. (2019)  
Over three-month period, 137 Peripheral Intravenous 
Catheters had dwell time of greater than 96 hours.  
No negative outcomes during the intervention, 
including no increase in phlebitis rates.
McGuire, R.,  
Coronado, A., (2020) 
Implementing clinically indicated removal of Peripheral 
Intravenous Catheters (PVC) resulted in better patient 
experience with fewer PVC’s for course of treatment 
resulting in cost savings. 
